Wipfli Financial Advisors’s Guardant Health GH Stock Holding History

Wipfli Financial Advisors’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$66K	Buy	+1,222	New	+$62.7K	﹤0.01%	940

Other funds holding GH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Wipfli Financial Advisors's GH Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in Guardant Health (GH) in Q3 2022: 1,222 shares worth $66K. The stake represents ﹤0.01% of the portfolio and ranks #940 among its holdings.

327 funds tracked by Wall St. Rank hold GH as of Q3 2022.

Wipfli Financial Advisors held 1,222 shares of Guardant Health worth $66K as of Q3 2022.
Guardant Health was a new Wipfli Financial Advisors position in Q3 2022.
Guardant Health made up ﹤0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #940 holding.
327 funds tracked by Wall St. Rank held Guardant Health as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.